|
ZFYVE20 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.995000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.121400E-03 |
| Normal-vs-Stage2 |
2.159700E-02 |
| Normal-vs-Stage3 |
4.600100E-04 |
| Normal-vs-Stage4 |
3.832300E-04 |
| Stage1-vs-Stage2 |
8.674800E-01 |
| Stage1-vs-Stage3 |
2.693800E-01 |
| Stage1-vs-Stage4 |
1.361190E-01 |
| Stage2-vs-Stage3 |
5.456200E-01 |
| Stage2-vs-Stage4 |
4.021200E-01 |
| Stage3-vs-Stage4 |
7.143400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.553800E-04 |
| Normal-vs-AfricanAmerican |
2.815600E-01 |
| Normal-vs-Asian |
9.009900E-02 |
| Caucasian-vs-AfricanAmerican |
2.951400E-01 |
| Caucasian-vs-Asian |
3.506200E-01 |
| AfricanAmerican-vs-Asian |
7.744400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.604300E-03 |
| Normal-vs-Female |
6.991800E-04 |
| Male-vs-Female |
7.699400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.932060E-02 |
| Normal-vs-Age(41-60Yrs) |
1.235190E-03 |
| Normal-vs-Age(61-80Yrs) |
1.228920E-04 |
| Normal-vs-Age(81-100Yrs) |
2.515800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.865000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.667900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.481200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.840000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.813000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.043400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.146000E-02 |
| Classical-VS-Follicular |
3.42630000005339E-06 |
| Classical-VS-Other |
2.024000E-01 |
| Classical-VS-Normal |
3.076500E-02 |
| Tall-VS-Follicular |
2.938400E-01 |
| Tall-VS-Other |
7.033400E-01 |
| Tall-VS-Normal |
1.019840E-03 |
| Follicular-VS-Other |
8.172000E-01 |
| Follicular-VS-Normal |
8.99640000051605E-07 |
| Other-VS-Normal |
5.040400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.384300E-04 |
| Normal-vs-N1 |
1.276450E-03 |
| N0-vs-N1 |
5.736600E-01 |
|
|
